U.S. Physical Therapy Inc(USPH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 515.89 | EPS (ttm) | 0.17 | Insider Own | 2.57% | Shs Outstand | 14.9M | Perf Week | 0.37% |
| Market Cap | 1.30B | Forward P/E | 25.67 | EPS next Y | 17.81% | Insider Trans | 0.21% | Shs Float | 14.5M | Perf Month | 1.45% |
| Enterprise Value | 1.98B | PEG | 2.14 | EPS next Q | 0.76 | Inst Own | 109.55% | Short Float | 8.22% | Perf Quarter | 9.38% |
| Income | 0.00B | P/S | 1.6 | EPS this Y | 9.81% | Inst Trans | 1.92% | Short Ratio | 6.23 | Perf Half Y | 20.4% |
| Sales | 0.81B | P/B | 2.91 | EPS next 5Y | 12% | ROA | 0.21% | Short Interest | 1.19M | Perf YTD | 11.85% |
| Book/sh | 30.06 | P/C | 52.36 | EPS past 3/5Y | -14.24% -10.5% | ROE | 0.54% | 52W High | -6.35% ($93.26) | Perf Year | -4.02% |
| Cash/sh | 1.67 | P/FCF | 20.01 | Sales past 3/5Y | 12.19% 13.05% | ROIC | 0.33% | 52W Low | 50.09% ($58.19) | Perf 3Y | 3.36% |
| Dividend Est. | $1.84 (2.11%) | EV/EBITDA | 19.36 | EPS Y/Y TTM | -92.59% | Gross Margin | 17.45% | Volatility(W/M) | 4.26% 3.15% | Perf 5Y | -14.53% |
| Dividend TTM | 1.83 | EV/Sales | 2.44 | Sales Y/Y TTM | 11.32% | Oper. Margin | 9.85% | ATR (14) | 2.74 | Perf 10Y | 49.91% |
| Dividend Ex-Date | 2026/8/21 | Quick Ratio | 1.27 | EPS Q/Q | -56.45% | Profit Margin | 0.32% | RSI (14) | 58.79 | Recom | 1.29 |
| Dividend Gr. 3/5Y | 3.15% 41.26% | Current Ratio | 1.27 | Sales Q/Q | 8.47% | SMA20 | 2.2% ($85.46) | Beta | 1.16 | Target Price | $97.83 |
| Payout | 126.62% | Debt/Eq | 0.86 | Earnings | 2026/11/4 | SMA50 | 6.03% ($82.37) | Rel Volume | 0.98 | Prev Close | $88.65 |
| Employees | 7294 | LT Debt/Eq | 0.75 | EPS/Sales Surpr. | -7.82% 1.28% | SMA200 | 13.82% ($76.74) | Avg Volume(3M) | 0.19M | Price | $87.34 |
| IPO | 1992/5/28 | Option/Short | Yes/Yes | Trades | 3341 | Volume | 187,968 | Change | -1.48% |
U.S. Physical Therapy (USPH) is a healthcare company that operates and manages outpatient physical therapy clinics across the United States. Its core services focus on orthopedic and sports injury rehabilitation, post-surgical recovery, and neurological injury treatment, along with workplace injury prevention services. Leveraging a network of clinics distributed across multiple states, the company delivers community-based rehabilitative care.
Over the past 1 year, on the higher side
6% below its 1-year high.
Traded about as much as usual. That is 98% of its average volume.
Next earnings report: November 4
7 days to go.
USPH earns at a steady pace
Of every $100 in sales, $9.85 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.8% this year.
Tap to view numbers
However, it looks expensive
Counting its debt, for $100 of yearly operating cash you would pay $1,936. Peers typically go for $1,288. Compared with its own 5-year average, it is 12% pricier now.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -14.5%. The S&P 500 did +70% over the same period.
Tap to view numbers
Dividends are more than it earns
It pays out 127% of what it earns.
Tap to view numbers
Ownership looks stable
Institutions hold 109.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #30 of 48 in the industry
Based on market cap of $1B.
AGL#27 Agilon Health Inc $2B PER - 
PNTG#28 Pennant Group Inc $1B PER 46.0 
NUTX#29 Nutex Health Inc $1B PER 8.2 USPH#30 U.S. Physical Therapy Inc $1B PER 515.9 
INNV#31 InnovAge Holding Corp $1B PER - 
FAQ
What kind of company is USPH?
USPH belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of USPH?
The market cap of USPH is approximately $1.3B, ranking 2,387 within its sector.
Does USPH pay dividends?
USPH has a dividend yield of approximately 2.11%, with an annual dividend of $1.84.
What is the P/E ratio of USPH?
USPH has a P/E ratio of approximately 515.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for USPH?
USPH has recorded a 52-week high of $93.26 and a low of $58.19.
